| Recruiting | 4 | 55 | US | coagulation factor VIIa [recombinant]-jncw, SEVENFACT | American Thrombosis and Hemostasis Network, LFB USA, Inc. | Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | 09/26 | 03/27 | | |
PINES, NCT03939637: Eltrombopag Vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children |
|
|
| Active, not recruiting | 3 | 122 | US | Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin | Baylor College of Medicine, Boston Children's Hospital, University of California, San Francisco | Immune Thrombocytopenia | 03/25 | 12/25 | | |
NCT04583878: FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease |
|
|
| Recruiting | N/A | 125 | US | Blood draw (Visit 1), Blood draw (Visits 2 and 3) | University of Texas Southwestern Medical Center | Deep Venous Thrombosis, Pulmonary Embolism | 06/25 | 12/25 | | |
| Recruiting | N/A | 3000 | US | | American Thrombosis and Hemostasis Network, Pfizer, Hemophilia of Georgia, Inc., Genentech, Inc., Hemab Therapeutics, CSL Behring, Sanofi, Novo Nordisk A/S | Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder, Hemophilia, Thrombosis, Von Willebrand Diseases, Thrombophilia, Rare Bleeding Disorder, Platelet Disorder, Factor IX Deficiency, Factor VIII Deficiency, Thalassemia, Sickle Cell Disease | 06/35 | 12/35 | | |
